caffeic acid phenethyl ester has been researched along with Neuroblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dos Santos, AC; Dos Santos, NAG; Fernandes, LS; Ferreira, RS; Martins, NM | 1 |
1 other study(ies) available for caffeic acid phenethyl ester and Neuroblastoma
Article | Year |
---|---|
Caffeic Acid Phenethyl Ester (CAPE) Protects PC12 Cells from Cisplatin-Induced Neurotoxicity by Activating the NGF-Signaling Pathway.
Topics: Analysis of Variance; Animals; Caffeic Acids; Cell Differentiation; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Enzyme Inhibitors; GAP-43 Protein; Nerve Growth Factor; Neuroblastoma; Neurofilament Proteins; Neuronal Outgrowth; Neuroprotective Agents; Neurotoxins; PC12 Cells; Phenylethyl Alcohol; Rats; Signal Transduction; Synapsins; Synaptophysin | 2018 |